DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Stein S, Pishvaian M, Lee MS. et al.
Safety and clinical activity of 1L atezolizumab + bevacizumab in a phase Ib study in hepatocellular carcinoma (HCC).
J Clin Oncol 2018;
36: 4074
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.